TapewireFind a company

person · Reporting owner

Kurzius Lawrence Erik

Disclosed activity across 4 companies

Tapewire entity
20811
SEC CIK
0001352090

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
COOPER COMPANIES, INC.COO · Entity 3395DirectorSeptember 16, 2026September 17, 2026
Elanco Animal Health IncELAN · Entity 3457DirectorAugust 20, 2026August 21, 2026
Lamb Weston Holdings, Inc.LW · Entity 3684DirectorOctober 08, 2026October 09, 2026
MCCORMICK & CO INCMKC · Entity 141610% ownerAugust 10, 2026August 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COOPER COMPANIES, INC.

Report date September 16, 2026 · Filed September 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect31,099 Reported balance After 2026-09-16 transaction · row 1
1 source row

Row 1 · 2026-09-16 · Purchase · Acquired 10,000 · Balance 31,099

Elanco Animal Health Inc

Report date August 20, 2026 · Filed August 21, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect188,647 Reported balance After 2026-08-20 transaction · row 1
1 source row

Row 1 · 2026-08-20 · Purchase · Acquired 40,000 · Balance 188,647

F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Lamb Weston Holdings, Inc.

Report date October 08, 2026 · Filed October 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect11,054 Reported balance After 2026-10-08 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-10-08 · Grant · Acquired 5,458 · Balance 11,054

F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

MCCORMICK & CO INC

Report date August 10, 2026 · Filed August 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock - VotingSEC Table I · non-derivativeDirect296,992 Ending reported balance After 2026-08-10 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-08-10 · Exercise / conversion · Acquired 205,538 · Balance 502,530

Row 2 · 2026-08-10 · Sale · Disposed 205,538 · Balance 296,992

Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2027-03-29Direct0 Reported balance After 2026-08-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-08-10 · Exercise / conversion · Disposed 205,538 · Balance 0

F1: Option exercised; no purchase price required.

Filing footnotes · ownership attribution and instrument terms

F1: Option exercised; no purchase price required.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 08, 2026 Filed Oct 9, 2026 20:15 UTC Lamb Weston Holdings, Inc. LW · Entity 3684 GrantCommon Stock 5,458 $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000010 · form4-10092026_081001.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,054

F1 · shares: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2 · balance_after: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

Read SEC document
September 16, 2026 Filed Sep 17, 2026 20:22 UTC COOPER COMPANIES, INC. COO · Entity 3395 PurchaseCommon Stock 10,000 $54.93 $549,320.00
Disclosure

SEC source: 0001352090-26-000008 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,099

Read SEC document
September 14, 2026 Filed Sep 15, 2026 20:53 UTC COOPER COMPANIES, INC. COO · Entity 3395 PurchaseCommon Stock 10,000 $53.92 $539,150.00
Disclosure

SEC source: 0001352090-26-000007 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,099

Read SEC document
August 20, 2026 Filed Aug 21, 2026 20:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 40,000 $23.40 $935,920.00
Disclosure

SEC source: 0001352090-26-000006 · form4-08212026_080841.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,647

F1 · price: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 14:46 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 205,538 $0.00 Strike: $49.03 $0.00
Disclosure

SEC source: 0000063754-26-000294 · form4.xml · derivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 205,538 shares

Expires 2027-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Option exercised; no purchase price required.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 14:46 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 205,538 $52.69 $10,829,201.16
Disclosure

SEC source: 0000063754-26-000294 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,992

Read SEC document
August 10, 2026 Filed Aug 12, 2026 14:46 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 205,538 $49.03 $10,076,500.45
Disclosure

SEC source: 0000063754-26-000294 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:47 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 12,196 $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000003 · form4-05262026_080513.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,647

F2 · shares: Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:47 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 4,678 $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000003 · form4-05262026_080513.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,451

F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
April 01, 2026 Filed Apr 6, 2026 21:14 UTC COOPER COMPANIES, INC. COO · Entity 3395 GrantRestricted Stock Units · Derivative 3,779 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000001 · primarydocument.xml · derivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,779

Underlying: Common Stock · 3,779 shares

Expires not disclosed

F1 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited.

Read SEC document
April 01, 2026 Filed Apr 6, 2026 21:14 UTC COOPER COMPANIES, INC. COO · Entity 3395 Exercise / conversionRestricted Stock Units · Derivative 3,322 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000001 · primarydocument.xml · derivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited.

Read SEC document
April 01, 2026 Filed Apr 6, 2026 21:14 UTC COOPER COMPANIES, INC. COO · Entity 3395 Exercise / conversionCommon Stock 3,322 $0.00 $0.00
Disclosure

SEC source: 0001352090-26-000001 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,099

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 17:05 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 50,000 $0.00 Strike: $49.03 $0.00
Disclosure

SEC source: 0000063754-26-000110 · form4.xml · derivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,538

Underlying: Common Stock - Voting · 50,000 shares

Expires 2027-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Option exercised; no purchase price required.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 17:05 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 50,000 $71.63 $3,581,500.00
Disclosure

SEC source: 0000063754-26-000110 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,992

Read SEC document
February 12, 2026 Filed Feb 13, 2026 17:05 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 50,000 $49.03 $2,451,250.00
Disclosure

SEC source: 0000063754-26-000110 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 19, 2026 Filed Jan 21, 2026 19:22 UTC MCCORMICK & CO INC MKC · Entity 1416 GrantCommon Stock - Voting 50,230 $0.00 $0.00
Disclosure

SEC source: 0000063754-26-000014 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,992

F1 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2022 and ending on November 30, 2025.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 21:03 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 50,000 Not disclosed Strike: $49.96 Not disclosed
Disclosure

SEC source: 0000063754-26-000009 · form4.xml · derivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 50,000 shares

Expires 2026-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Option Exercised.

Read SEC document
January 13, 2026 Filed Jan 14, 2026 21:03 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 50,000 $67.43 $3,371,500.00
Disclosure

SEC source: 0000063754-26-000009 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,762

Read SEC document
January 13, 2026 Filed Jan 14, 2026 21:03 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 50,000 $49.96 $2,498,000.00
Disclosure

SEC source: 0000063754-26-000009 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2025 Filed Dec 17, 2025 22:06 UTC COOPER COMPANIES, INC. COO · Entity 3395 PurchaseCommon Stock 2,000 $82.50 $165,000.00
Disclosure

SEC source: 0001352090-25-000012 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,777

Read SEC document
December 12, 2025 Filed Dec 16, 2025 21:42 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $21.30 $213,000.00
Disclosure

SEC source: 0001352090-25-000011 · form4-12162025_091243.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,773

Read SEC document
November 28, 2025 Filed Dec 2, 2025 22:05 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 10,314 $0.00 $0.00
Disclosure

SEC source: 0001352090-25-000009 · form4-12022025_101248.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,773

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 17:13 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 14,060 $64.54 $907,432.40
Disclosure

SEC source: 0000063754-25-000097 · form4.xml · nonDerivative · entry 6

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · BY 2025 GRAT K

Disclosed balance after: 0

Read SEC document
November 11, 2025 Filed Nov 12, 2025 17:13 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 5,903 $64.54 $380,979.62
Disclosure

SEC source: 0000063754-25-000097 · form4.xml · nonDerivative · entry 5

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2024 GRAT J

Disclosed balance after: 0

Read SEC document
November 11, 2025 Filed Nov 12, 2025 17:13 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 5,903 $64.54 $380,979.62
Disclosure

SEC source: 0000063754-25-000097 · form4.xml · nonDerivative · entry 4

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2024 GRAT I

Disclosed balance after: 0

Read SEC document
November 11, 2025 Filed Nov 12, 2025 17:13 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 6,574 $64.54 $424,285.96
Disclosure

SEC source: 0000063754-25-000097 · form4.xml · nonDerivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 GRAT H

Disclosed balance after: 0

Read SEC document
November 11, 2025 Filed Nov 12, 2025 17:13 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 6,574 $64.54 $424,285.96
Disclosure

SEC source: 0000063754-25-000097 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 GRAT G

Disclosed balance after: 0

Read SEC document
October 08, 2025 Filed Oct 10, 2025 13:40 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 50,000 $0.00 Strike: $65.86 $0.00
Disclosure

SEC source: 0000063754-25-000072 · form4.xml · derivative · entry 8

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock - Voting · 50,000 shares

Expires 2026-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Options Exercised; No Purchase Price Required.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 13:40 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 50,000 $65.86 $3,293,000.00
Disclosure

SEC source: 0000063754-25-000072 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,762

Read SEC document
October 08, 2025 Filed Oct 10, 2025 13:40 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 50,000 $49.96 $2,498,000.00
Disclosure

SEC source: 0000063754-25-000072 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 20:28 UTC Lamb Weston Holdings, Inc. LW · Entity 3684 GrantCommon Stock 4,345 $0.00 $0.00
Disclosure

SEC source: 0001352090-25-000007 · form4-10032025_081017.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

F1 · shares: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the first annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders occurring after the date of grant, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2 · balance_after: Includes 7 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

Read SEC document
September 29, 2025 Filed Sep 30, 2025 00:36 UTC COOPER COMPANIES, INC. COO · Entity 3395 PurchaseCommon Stock 2,000 $68.39 $136,780.00
Disclosure

SEC source: 0001352090-25-000005 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,777

Read SEC document
July 25, 2025 Filed Jul 28, 2025 22:46 UTC Lamb Weston Holdings, Inc. LW · Entity 3684 GrantCommon Stock 1,109 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-020413 · form4-07282025_100705.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,109

F1 · shares: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the first annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders occurring after the date of grant, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 14:20 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 675 $76.88 $51,894.00
Disclosure

SEC source: 0001062993-25-012422 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,762

F1 · shares: Shares withheld for taxes on previously vested awards subject to deferred receipt.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 15:22 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherCommon Stock - Voting 15,654.06 $73.14 $1,144,937.95
Disclosure

SEC source: 0001062993-25-011106 · form4.xml · nonDerivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · 401(k) Retirement Plan

Disclosed balance after: 0

F2 · shares: In the reported transaction, the reporting person disposed units from the McCormick & Company, Inc. 401(k) Retirement Plan that represented 15,654.06 shares of common stock, by executing an intra-plan transfer.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 19:21 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 31,816.591 $73.44 $2,336,610.44
Disclosure

SEC source: 0001062993-25-010976 · form4.xml · derivative · entry 9

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Non Qualified Retirement Savings Plan

Disclosed balance after: 0

Underlying: Common Stock - Voting · 31,816.591 shares

Expires not disclosed

F2 · derivative.exercise_price: In the reported transaction, the reporting person disposed units from the Non-Qualified Retirement Savings Plan that represented 31,816.591 shares of common stock, by executing an intra-plan transfer.

F2 · derivative.exercise_date: In the reported transaction, the reporting person disposed units from the Non-Qualified Retirement Savings Plan that represented 31,816.591 shares of common stock, by executing an intra-plan transfer.

F2 · derivative.expiration_date: In the reported transaction, the reporting person disposed units from the Non-Qualified Retirement Savings Plan that represented 31,816.591 shares of common stock, by executing an intra-plan transfer.

Read SEC document
April 21, 2025 Filed Jun 4, 2025 19:21 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 190.596 $74.67 $14,231.80
Disclosure

SEC source: 0001062993-25-010976 · form4.xml · derivative · entry 8

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Non-Qualified Retirement Savings Plan

Disclosed balance after: 31,816.591

Underlying: Common Stock - Voting · 190.596 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend Reinvestment

F1 · derivative.exercise_date: Dividend Reinvestment

F1 · derivative.expiration_date: Dividend Reinvestment

Read SEC document
April 02, 2025 Filed Apr 2, 2025 18:43 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 50,000 $0.00 Strike: $81.81 $0.00
Disclosure

SEC source: 0001062993-25-006802 · form4.xml · derivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 50,000 shares

Expires 2026-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Option exercised; No purchase price required.

Read SEC document
April 02, 2025 Filed Apr 2, 2025 18:43 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 50,000 $81.81 $4,090,300.00
Disclosure

SEC source: 0001062993-25-006802 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,437

Read SEC document
April 02, 2025 Filed Apr 2, 2025 18:43 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 50,000 $49.96 $2,498,000.00
Disclosure

SEC source: 0001062993-25-006802 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:07 UTC COOPER COMPANIES, INC. COO · Entity 3395 GrantRestricted Stock Units · Derivative 3,322 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-25-002968 · primarydocument.xml · derivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,322

Underlying: Common Stock · 3,322 shares

Expires not disclosed

F1 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:07 UTC COOPER COMPANIES, INC. COO · Entity 3395 Exercise / conversionRestricted Stock Units · Derivative 2,721 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562180-25-002968 · primarydocument.xml · derivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,721 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:07 UTC COOPER COMPANIES, INC. COO · Entity 3395 Exercise / conversionCommon Stock 2,721 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-002968 · primarydocument.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 22:18 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionRestricted Stock Units · Derivative 1,734 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005798 · form4.xml · derivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,469

Underlying: Common Stock - Voting · 1,734 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required.

F4 · price: Restricted Stock Units granted on December 2, 2024.

F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2025, March 15, 2026 and March 15, 2027.

F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2025, March 15, 2026 and March 15, 2027.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 22:18 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 1,734 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005798 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units; No purchase price required.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:18 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 642 $80.18 $51,475.56
Disclosure

SEC source: 0001062993-25-005798 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,437

Read SEC document
March 11, 2025 Filed Mar 11, 2025 21:13 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $10.20 $102,000.00
Disclosure

SEC source: 0001415889-25-007681 · form4-03112025_090327.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,459

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:13 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $10.90 $109,000.00
Disclosure

SEC source: 0001415889-25-007681 · form4-03112025_090327.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,459

Read SEC document
February 18, 2025 Filed Feb 20, 2025 00:25 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 30,550 $76.96 $2,351,128.00
Disclosure

SEC source: 0001062993-25-002946 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,345

F1 · shares: Shares withheld for taxes on the shares previously reported on 1/29/2025 for McCormick's Long-Term Incentive Plan.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 20:15 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 50,000 $0.00 Strike: $76.81 $0.00
Disclosure

SEC source: 0001062993-25-001602 · form4.xml · derivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock - Voting · 50,000 shares

Expires 2026-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Optins exercised; No purchase price required.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.